Insights

A Legal Outlook for Law Firms, Trial Lawyers, and Mass Tort Counsel The rapid rise of GLP-1 receptor agonist drugs, including Ozempic®, Wegovy®, Rybelsus® (semaglutide), and Mounjaro® (tirzepatide), has reshaped both the diabetes and weight-loss markets. Alongside...

A Strategic Litigation Outlook for Law Firms, Trial Counsel & Mass Tort Teams As 2026 begins, one of the most closely watched and rapidly evolving areas of complex litigation is the wave of social media harm lawsuits targeting major technology companies over...

A Strategic Litigation Analysis for Law Firms, Trial Lawyers & Mass Tort Counsel As hair relaxer litigation continues expanding in 2026, the intersection of emerging epidemiological evidence and evolving federal MDL proceedings is reshaping how plaintiffs’ and...

Institutional Abuse Litigation Overview Institutional abuse litigation continues to expand nationwide as survivors come forward with claims alleging sexual abuse, physical abuse, and systemic misconduct by schools, religious organizations, youth programs, detention...

California Institutional Abuse Litigation Overview California remains one of the most active jurisdictions in the country for institutional abuse litigation. Expanded statutes of limitations, increased regulatory oversight, and heightened survivor awareness have...

Roblox Abuse Lawsuits and Digital Platform Accountability Introduction As online gaming and social platforms continue to attract millions of child users, litigation involving alleged abuse facilitated through platforms like Roblox is gaining momentum. In 2026, Roblox...